Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

S. B. Van Waalwijk Van Doorn-Khosrovani, A. Pisters-Van Roy, L. Van Saase, M. Van Der Graaff, J. Gijzen, S. Sleijfer, L. R. Hoes, J. M. Van Berge Henegouwen, H. Van Der Wijngaart, D. L. Van Der Velden, E. Van Werkhoven, V. P. Retel, W. H. Van Harten, A. D.R. Huitema, L. Timmers, H. Gelderblom, H. M.W. Verheul, E. E. Voest*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)663-665
Number of pages3
JournalAnnals of oncology
Volume30
Issue number5
Early online date26 Apr 2019
DOIs
Publication statusPublished - 1 May 2019

Keywords

  • UT-Hybrid-D

Cite this

Van Waalwijk Van Doorn-Khosrovani, S. B., Pisters-Van Roy, A., Van Saase, L., Van Der Graaff, M., Gijzen, J., Sleijfer, S., ... Voest, E. E. (2019). Personalised reimbursement: A risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients. Annals of oncology, 30(5), 663-665. https://doi.org/10.1093/annonc/mdz119